Key result
Pretreatment with ATL-146e reduced the total length of aspirin-induced gastric erosions in rats compared to control.
Why the study?
Does ATL-146e prevent aspirin-induced gastric mucosal lesions and inflammation in rats?
Does ATL-146e prevent aspirin-induced gastric mucosal lesions and inflammation in rats?
The adenosine A2A receptor agonist ATL-146e demonstrates potent anti-ulcer and anti-inflammatory effects against aspirin-induced gastric lesions in a rat model.
Answers are grounded in this paper and cite their sources.
Should not yet influence clinical aspirin use; leaves open translation of A2A agonism to human gastroprotection.
AIM: To determine whether a specific adenosine A(2A) receptor agonist (ATL-146e) can ameliorate aspirin-induced gastric mucosal lesions in rats, and reduce neutrophil accumulation and production of pro-inflammatory cytokines. METHODS: Gastric lesions were produced by oral gavage of aspirin (200 mg/kg) and HCl (0.15 mol/L, 8.0 mL/kg). 4-{3-[6-Amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester (ATL-146e, 2.5-5 mug/kg, IP) was injected 30 min before the administration of aspirin. Tissue myeloperoxidase (MPO) concentration in gastric mucosa was measured as an index of neutrophil infiltration. Gastric mucosal concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) were determined by ELISA. Also, we examined the effect of ATL-146e on tissue prostaglandin E2 (PGE2) production and gastric secretion. RESULTS: Intragastric administration of aspirin induced multiple hemorrhagic erosions in rat gastric mucosa. The total length of gastric erosions (ulcer index) in control rats was 29.8+/-7.75 mm and was reduced to 3.8+/-1.42 mm after pretreatment with 5.0 g/kg ATL-146e (P<0.01). The gastric contents of MPO and pro-inflammatory cytokines were all increased after the administration of aspirin and reduced to nearly normal levels by ATL-146e. Gastric mucosal PGE2 concentration was not affected by intraperitoneal injection of ATL-146e. CONCLUSION: The specific adenosine A(2A) receptor agonist, ATL-146e, has potent anti-ulcer effects presumably mediated by its anti-inflammatory properties.
No takes yet. Share an insight, caveat, or question.
Masaru Odashima (2006) studied Aspirin-induced gastric mucosal lesions. ATL-146e vs. Control was evaluated on Total length of gastric erosions (ulcer index) (p=<0.01). Pretreatment with ATL-146e reduced the total length of aspirin-induced gastric erosions in rats compared to control.
Synapse has enriched 10 related papers. Consider them for comparative context: